Berkeley

Berkeley Lights (now part of Bruker as Bruker Cellular Analysis) is a leading digital cell biology company that focuses on enabling and accelerating the rapid development and commercialization of biotherapeutics and other cell-based products. The company's core technology, the Beacon optofluidic platform, integrates proprietary optofluidic technology and microfluidic chips to isolate, characterize, and manipulate thousands of single cells simultaneously. This high-throughput platform is used by pharmaceutical and biotech companies for antibody discovery, cell line development, and cell therapy research. By providing deep phenotypic insights at the single-cell level, Berkeley Lights helps researchers identify the best cells for their specific therapeutic needs much faster than traditional methods.